Mark Erlander is Chief Scientific Officer at Trovagene, Inc. (TROV). They have made 4 open-market trades across 2 companies since 2016, most recently 2022-11-25.
CIK 0001651537
4 open-market purchases totalling $45K since 2016, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.